CNSX:BUX - BioMark Diagnostics Stock Price, News, & Analysis

-0.01 (-7.14 %)
(As of 07/17/2019 01:33 PM ET)
Today's Range
Now: $0.13
50-Day Range
MA: $0.15
52-Week Range N/A
Volume17,500 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions that allows for cancer detection, monitoring, and assessing treatment. The company was incorporated in 2014 and is headquartered in Richmond, Canada. Biomark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.

Industry, Sector and Symbol

Industry Diagnostics & Research



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive BUX News and Ratings via Email

Sign-up to receive the latest news and ratings for BUX and its competitors with MarketBeat's FREE daily newsletter.

BioMark Diagnostics (CNSX:BUX) Frequently Asked Questions

What is BioMark Diagnostics' stock symbol?

BioMark Diagnostics trades on the CNSX under the ticker symbol "BUX."

Has BioMark Diagnostics been receiving favorable news coverage?

Media stories about BUX stock have trended somewhat positive recently, according to InfoTrie Sentiment. The research firm ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. BioMark Diagnostics earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for BioMark Diagnostics.

Who are some of BioMark Diagnostics' key competitors?

Who are BioMark Diagnostics' key executives?

BioMark Diagnostics' management team includes the folowing people:
  • Mr. Rashid Ahmed Bux, Founder, CEO, Pres & Director
  • Mr. Brian Cheng, CTO & Director
  • Gina Huang, CFO & Project Director
  • Dr. Thomas Malcolm Ph.D., Chief Scientific Officer
  • Neal Kaplan, Chief Financial Officer of US

How do I buy shares of BioMark Diagnostics?

Shares of BUX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BioMark Diagnostics' stock price today?

One share of BUX stock can currently be purchased for approximately $0.13.

What is BioMark Diagnostics' official website?

The official website for BioMark Diagnostics is

How can I contact BioMark Diagnostics?

The company can be reached via phone at 604-370-0779.

MarketBeat Community Rating for BioMark Diagnostics (CNSX BUX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  8 (Vote Outperform)
Underperform Votes:  8 (Vote Underperform)
Total Votes:  16
MarketBeat's community ratings are surveys of what our community members think about BioMark Diagnostics and other stocks. Vote "Outperform" if you believe BUX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BUX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/17/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel